Montco biopharm to collaborate with the Parker Institute for Cancer Immunotherapy
January 09, 2018 at 13:31 PM EST
Their first target is bladder cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|